IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1059-1064

  Yoshidome, Hiroyuki ^a   Kato, Atsushi ^a   Miyazaki, Masaru ^a   Edwards, Michael J ^a   Lentsch, Alex B ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER PROTECTIVE AGENT; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; RECOMBINANT INTERLEUKIN 13; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0032857208     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65208-X     Document Type: Article

References (34)

1. Huguet C, Gavelli A, Bona S: Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 1994, 178:454-458
2. Liu DL, Jeppsson B, Hakansson CH, Odselius R: Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 1996, 131:442-447
3. Lemasters JJ, Thurman RG: Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997, 37:327-338
4. Vedder NB, Fouty BW, Winn RK, Harlan JM, Rice CL: Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery 1989, 106:509-516
5. Jaeschke H, Farhood A: Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991, 260:G355-G362
6. Wanner GA, Ertel W, Muller P, Hofer Y, Leiderer R, Menger MD, Messmer K: Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996, 5:34-40
7. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA, Jr: Role of tumor necrosis factor-α in the pathophysiologic alternations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990, 85:1936-1943
8. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukec Biol 1995, 57:368-374
9. Colletli LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM: Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998, 10:182-191
10. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ: Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998, 27:1172-1177
11. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM: Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: the role of epithelial neutrophil activating protein. J Clin Invest 1995, 95:134-141
12. Vollmar B, Richter S, Menger MD: Leukocyte stasis in hepatic sinusoids. Am J Physiol 1996, 270:G798-G803
13. Jaeschke H, Smith CW: Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997, 61:647-653
14. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatosis P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250
15. de Waal Malefyt R, Rgdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993, 151:6370-6381
16. Deleuran B, Iversen L, Deleuran M, Yssel H, Kragballe K, Stengaard-Pedersen K, Thestrup-Pedersen K: Interteukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC: a comparison between IL-4 and IL-13. Cytokine 1995, 7:319-324
17. Berkman N, John M, Roesems G, Jose P, Barnes PJ, Chung KF: Interleukin 13 inhibits macrophage inflammatory protein-1α production from human alveolar macrophages and monocytes. Am J Respir Cell Mol Biol 1996, 15:382-389
18. Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA: IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production. J Immunol 1997, 158:2898-2903
19. Doyle AG, Herbein G, Montaner LJ, Minty A, Caput D, Ferrara P, Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur J Immunol 1994, 24:1441-1445
20. Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA: Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury. J Immunol 1997, 159:3483-3489
21. Lentsch AB, Shanley TP, Sarma V, Ward PA: In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J Clin Invest 1997, 100:2443-2443
22. Manna SK, Aggarwal BB: IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J Immunol 1998, 161:2863-2872
23. Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, Niho Y, Harada N: Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 1996, 271:619-622
24. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J lmmunol 1996, 157:3220-3222
25. Deryckere F, Gannon F: A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 1994, 16:405
26. Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 suppresses hepatic ischermia/reperfusion injury in mice: implications for a central role of NFκB. Hepatology 1999, 30:203-208
27. Gabay C, Porter B, Guenette D, Billir B, Arend WP: Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1β on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999, 93:1299-1307
28. Heim MH, Gamboni G, Beglinger C, Gyr K: Specific activation of AP-1 but not Stat3 in regenerating liver in mice. Eur J Clin Invest 1997, 27:948-955
29. Bennett BL, Cruz R, Lacson RG, Manning AM: Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB. J Biol Chem 1997, 272:10212-10219
30. Ryan JJ, DeSimone S, Klisch G, Shelburne C, McReynolds U, Han K, Kovacs R, Mirmonsef P, Huff TF: IL-4 inhibits mouse mast cell FcεRI expression through a STAT6-dependent mechanism. J Immunol 1998, 161:6915-6923
31. Kaplan MH, Daniel C, Schindler U, Grusby MJ: Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol 1998, 18:1996-2003
32. Levings MK, Schrader JW: IL-4 inhibits the production of TNF-α and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol 1999, 162:5224-5229
33. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF: Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor κB independently of IκB degradation. Hepatology 1998, 28:1022-1030
34. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF: Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996, 86:787-798